Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FDA draft guidance on computerised systems used in clinical trials.

Maria E Donawa1,

  • 1Donawa & Associates Ltd, Rome, Italy. medonawa@donawa.com

Medical Device Technology
|December 13, 2005
PubMed
Summary

Managing clinical study computer systems requires understanding control measures and United States (US) regulations for electronic records and signatures, especially for regulatory submissions. This article addresses these critical aspects and a draft guidance document.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New European guidance on borderline products.

Medical device technology·2009
Same author

The evolving process of European combination product review, Part II.

Medical device technology·2009
Same author

The evolving process of European combination product review, Part I.

Medical device technology·2008
Same author

Who owns the 510(k)?

Medical device technology·2008
Same author

The essential element of ethics.

Medical device technology·2004
Same author

Guidance on submitting quality system information.

Medical device technology·2004

Area of Science:

  • Clinical research informatics
  • Regulatory science
  • Information technology in healthcare

Background:

  • Effective management of clinical study computer systems is crucial for data integrity and regulatory compliance.
  • Understanding the application of US regulations on electronic records and signatures is essential for studies supporting regulatory submissions.

Purpose of the Study:

  • To discuss the control of computer systems used in clinical studies.
  • To clarify the applicability of US electronic records and signatures regulations for regulatory submissions.
  • To present and analyze a draft guidance document addressing these issues.

Main Methods:

  • Review of existing regulations concerning electronic records and signatures in the US.
  • Analysis of best practices for controlling computer systems in clinical trial management.

Related Experiment Videos

  • Examination of a draft guidance document relevant to these topics.

    • Main Results:

    • Identification of key control considerations for clinical study computer systems.
    • Clarification of the circumstances under which US electronic records and signatures regulations apply.
    • Insights into the recommendations and implications of the draft guidance document.

    Conclusions:

    • Proper control of clinical study computer systems is vital for regulatory compliance.
    • Awareness and adherence to US electronic records and signatures regulations are mandatory for relevant submissions.
    • The draft guidance document offers valuable direction for managing these systems and regulatory requirements.